UK Markets closed

Chugai Pharmaceutical Co., Ltd. (CHGCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
26.460.00 (0.00%)
As of 09:30AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 335.01
52-week low 322.86
50-day moving average 324.59
200-day moving average 326.68

Share statistics

Avg vol (3-month) 31.94k
Avg vol (10-day) 3N/A
Shares outstanding 51.64B
Implied shares outstanding 6N/A
Float 8636.59M
% held by insiders 159.99%
% held by institutions 118.25%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.66
Forward annual dividend yield 42.60%
Trailing annual dividend rate 355.00
Trailing annual dividend yield 3207.83%
5-year average dividend yield 4N/A
Payout ratio 435.53%
Dividend date 331 Aug 2017
Ex-dividend date 428 Dec 2022
Last split factor 23:1
Last split date 328 Jun 2020

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 32.42%
Operating margin (ttm)45.72%

Management effectiveness

Return on assets (ttm)21.40%
Return on equity (ttm)30.91%

Income statement

Revenue (ttm)1.14T
Revenue per share (ttm)695.34
Quarterly revenue growth (yoy)-21.60%
Gross profit (ttm)661.61B
EBITDA 575.67B
Net income avi to common (ttm)370.8B
Diluted EPS (ttm)1.17
Quarterly earnings growth (yoy)-21.20%

Balance sheet

Total cash (mrq)545.3B
Total cash per share (mrq)331.48
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.21
Book value per share (mrq)597.67

Cash flow statement

Operating cash flow (ttm)469.75B
Levered free cash flow (ttm)298.8B